泰凌医药2023中期报告

(於開曼群島註冊成立之有限公司) 中 期 報 告2 0 2 3 2 3 12 17 18 19 21 22 23 198The Wellington 28 121803–05 20231 1920231 19 Cricket Square, Hutchins DrivePO Box 2681Grand Cayman, KY1-1111Cayman Islands 1617 Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DrivePO Box 2681Grand Cayman, KY1-1111Cayman Islands (852) 2808 1606(852) 2508 9459ir@ntpharma.com http://www.ntpharma.com 1011 202020 82.6202237.927.9202220.35.6202222.6 2022COVID-19 2021A2.27725.3%2,000 220232,000–3,000 3 37.982.62022120.5 20236 3015.330.3202245.6 20236 3022.652.3202274.920236 301.263.3%202262.1%20236 30 20236 301.02.8%33.9202234.92022 20236 3020220.9 20236 305.6202228.2 20236 304,00020225,000 2023630348.120221231348.14.5% 20236 30503.1202212 31476.9 20236 30465.2202212 31465.2 20236 30202212 31 20236 30 (a)20211 524,455,00012,000 20219924,467,000 2022202112 313,560,00020218,984,000202212 3137,011,000202133,451,000 (b)20218 2468,231,000 20219 2763,700,0004,531,000202112 3122,157,000 202222268,231,000 202212 31202212 312,490,000 202212 3170,721,000202168,231,000 (c)20219 1734,911,000 202110 2820221231,400,0004,211,0002,166,000 2022202112 31 (d)202112 6101,000,000 202212 3121,375,000202112 3110,552,000 (e)20222 11119,000,000 20225 1820225 20 202212 31119,000,0007,992,000 (f)20228 29160,000,000202212 31 202212 31160,000,0007,432,000 20236 30 20236 30 20236 3012420226 3019010.220226 3013.9 20149 2220159 4 20236 30A.2.1 20236 30 20236 302022 20236 30 20236 30 25% 20114 750,027,8812020 20149 22201411106,300,0001.252014201511541,500,0001.232015 20149 420142015201411 1020151 1520236 3020236 30 20236 3020,200,000 1 20236 30571XV352 500,0002015115 (2)Golden Base Investment LimitedGolden Base402,892,000GoldenBase (3)20236 302,377,822,06320236 30 20236 3018352 20236 30XV336 (1)Annie Investment Co.,Ltd.1,700,000527,381,50020236 3022.25% (2)20236 302,377,822,0632023630 20236 30XV336 20236 30 20236 30 •35530 •1••• 20235 220237 2520238 21 20236 30 20236 30 20236 30 20236 30 1. 34 2. (a) 20236 3020221231 (b) 20236 305,612,00020236 301,111,611,000247,813,000851,242,000847,966,00020236 3020236 3012,058,000 20236 30 2. (b) (i)(ii)202212 31(iii)(iv) 20236 30 20236 30 2. (b) (i)(ii)202312 31(iii)(iv)(v) 20236 30 3. 8 202320226 3010% 15 20236 30 4. 5. 6. 20236 30 7. (ii)16.5%202216.5%20236 30 20236 3025%202225%15%202215% 8. (a) 20236 305,612,000202228,238,0002,244,493,00020221,889,613,000 (b) 202320226 30 20236 30 9. 20236 3020221,725,0001,937,0002022363,000 10. 60180 20236 30 11. 20236 30 12. 20236 30 13. (a) (b) 20236 302022 (c) 20236 30 (i)20103 150,100626,250,0000.00000008 (ii)20176 550,100626,925,000,0000.0000000850,100(i)625,925,000,0000.00000008(ii)325,000,0000.00000008 20236 30 14. NT Holdings20099 182009NT HoldingsNT Holdings 20114 7NT Holdings200920092009200920114 2070%20092009 20121 1120143 6 201492220142014(i)(ii)(iii)211 2014201410%1220141% 20236 30 14. 120.1%52014 20236 30 14. (b) 20236 3020140.1620210.16120222.02 (c) 20236 30 14. (c) 202320226 30 (d) 20159 4 2022202112 313,850,0002021800,000604,000202184,000202212 31 202212 3135,259,0002021 11,159,33620212,021,0002021 20236 30 15. (a)20236 30 20236 30202212 31 16. (i)20211524,455,00012,00024,467,000 20219 924,467,000 (ii)20218 2468,231,000 20219 2763,700,0004,531,00020221 668,231,000 20236 30 16. (iii)20219 1735,260,000 202110 2833,811,000202212 (iv)202112 6101,000,000 20236 30 20236 30 20236 30 17. 20236 30 20236 30 17. 18. •35530 •1 • • • 20235 220237 2520238 21